Sign in to view content

Pooled Clinical Trial Safety Data of Neurotrophic Factorâ€“Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2

Paul S. Bernstein, MD, PhD

Video
Published 2024

Related

Fas Inhibition With ONL1204 for the Treatment of Geographic Atrophy: First-Time Results From a Phase 1b Study
Durga Borkar, MD
Annual Meeting Talks
2024
TIE2, VEGF, and Integrin Receptor Interplay and its Role in Retinal Disease
Peter K. Kaiser, MD FASRS
Updates from the Field
2020
Comparison of CRISPR-based Genome Editing of VEGF-A as Treatment Strategy for Choroidal Neovascularization
Glenn C. Yiu, MD, PhD
Updates from the Field
2019

Category: Hereditary Retinal Disease & Genetics

See more